TSCQ study: a randomized, controlled, open-label trial of daily trimethoprim-sulfamethoxazole or weekly chloroquine among adults on antiretroviral therapy in Malawi: study protocol for a randomized controlled trial

BACKGROUND: Before antiretroviral therapy (ART) became widely available in sub-Saharan Africa, several studies demonstrated that daily trimethoprim-sulfamethoxazole (TS) prophylaxis reduced morbidity and mortality among HIV-infected adults. As a result, the World Health Organization (WHO) recommende...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Trials
Main Authors: Laurens, Matthew B., Mungwira, Randy G., Nyirenda, Osward M., Divala, Titus H., Kanjala, Maxwell, Muwalo, Francis, Mkandawire, Felix A., Tsirizani, Lufina, Nyangulu, Wongani, Mwinjiwa, Edson, Taylor, Terrie E., Mallewa, Jane, Blackwelder, William C., Plowe, Christopher V., Laufer, Miriam K., van Oosterhout, Joep J.
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2016
Assuntos:
Study Protocol
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4950772/
https://ncbi.nlm.nih.gov/pubmed/27431995
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13063-016-1392-3
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados